Atsushi Oyama Selected Research

Atsushi Oyama Research Topics

Disease

11	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2017
9	Neoplasms (Cancer) 01/2023 - 01/2008
4	Fibrosis (Cirrhosis) 10/2023 - 02/2002
4	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 02/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
2	End Stage Liver Disease 10/2023 - 02/2019
2	Non-alcoholic Fatty Liver Disease 08/2023 - 05/2021
2	Hyponatremia 05/2021 - 12/2020
2	Ascites 05/2021 - 12/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2020 - 12/2016
2	Inflammation (Inflammations) 05/2013 - 08/2012
1	Liver Failure 02/2022
1	Focal Nodular Hyperplasia 02/2022
1	Rupture 02/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 06/2021
1	Hyperaldosteronism (Conn Syndrome) 05/2021
1	Edema (Dropsy) 12/2020
1	Dehydration (Water Stress) 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Stomatitis 12/2020
1	Weight Loss (Weight Reduction) 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Venous Thromboembolism 11/2020
1	Chronic Hepatitis C 01/2020
1	Colitis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2019
1	Hepatitis B 02/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2019
1	Infections 02/2019
1	Pulmonary Hypertension 05/2018
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 05/2018
1	Wounds and Injuries (Trauma) 08/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2008
1	Rectal Neoplasms (Rectal Cancer) 01/2008
1	Adenocarcinoma 01/2008

Drug/Important Bio-Agent (IBA)

4	theanineIBA 12/2020 - 08/2012
4	Cystine (L-Cystine)IBA 12/2020 - 08/2012
3	SodiumIBA 10/2023 - 12/2020
3	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 01/2020
3	Amino Acids FDA Link 12/2020 - 05/2013
2	CytokinesIBA 08/2023 - 06/2019
2	Sorafenib (BAY 43-9006)FDA Link 06/2021 - 06/2019
2	Tolvaptan FDA Link 05/2021 - 12/2020
2	Glutathione (Reduced Glutathione)IBA 05/2013 - 08/2012
1	Becaplermin (PDGF-BB)FDA Link 08/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2023
1	Chemokine CCL5IBA 08/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	atezolizumabIBA 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 12/2022
1	Serum AlbuminIBA 02/2022
1	Technetium (Technetium 99m)IBA 02/2022
1	Everolimus FDA Link 01/2022
1	Laminin (Merosin)IBA 06/2021
1	Protein Isoforms (Isoforms)IBA 06/2021
1	IntegrinsIBA 06/2021
1	Natriuretic AgentsIBA 05/2021
1	Aquaporin 2IBA 05/2021
1	DiureticsIBA 05/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2021
1	Transaminases (Aminotransferases)IBA 05/2021
1	Circulating Tumor DNAIBA 04/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2021
1	acarboxyprothrombin (PIVKA)IBA 04/2021
1	Furosemide (Lasix)FDA LinkGeneric 12/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 12/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2020
1	AntioxidantsIBA 08/2020
1	Prothrombin (Factor II)IBA 07/2020
1	Fetal Proteins (Fetoprotein)IBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 06/2020
1	hepatitis B hyperimmune globulinIBA 02/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2019
1	VaccinesIBA 02/2019
1	Therapeutic UsesIBA 10/2017
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2008
1	Dehydroepiandrosterone (DHEA)IBA 03/2008
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2008
1	UroplakinsIBA 01/2008
1	Keratin-7 (Cytokeratin 7)IBA 01/2008
1	ThrombomodulinIBA 01/2008

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
4	Oral Administration 12/2020 - 08/2012
3	Therapeutics 01/2023 - 03/2017
3	Liver Transplantation 02/2022 - 05/2018
3	Radiofrequency Ablation 06/2021 - 03/2017
2	Adjuvant Chemotherapy 12/2016 - 01/2008
1	Operative Time 11/2020
1	Hepatectomy 01/2020
1	Stents 03/2019
1	Decompression 03/2019
1	Self Expandable Metallic Stents 03/2019
1	Perioperative Period 05/2013
1	Gastrectomy 05/2013
1	Intravenous Infusions 03/2008
1	Urinary Diversion (Ileal Conduit) 01/2008